Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

RICHARD A PARISI

Allopathic & Osteopathic Physicians Internal Medicine Sleep Medicine

NPI
1104813765
CMS profile
140305
Location
WILLIAMSBURG, VA

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2025 · Entire year

$3,285.06

136 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2025 · entire year · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $3,285.06 136

By paying entity

PY2025 · entire year · sorted by reported total

Page 3 of 3; records 101–136 of 136 matching records. This page contains 36 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

RICHARD A PARISI

NPI 1104813765 · CMS profile ID 140305

Allopathic & Osteopathic Physicians / Internal Medicine / Sleep Medicine

WILLIAMSBURG, VA

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 3 of 3; records 101–136 of 136 matching records. This page contains 36 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1104813765?year=2025&recipient=provider&page=3#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
RICHARD A PARISI, NPI 1104813765, CMS profile ID 140305. General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 3 of 3; records 101–136 of 136 matching records. This page contains 36 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1104813765?year=2025&recipient=provider&page=3#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e.
APA 7
IndustryPayments. (2026). RICHARD A PARISI, NPI 1104813765, CMS profile ID 140305. General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 3 of 3; records 101–136 of 136 matching records. This page contains 36 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1104813765?year=2025&recipient=provider&page=3#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e.
Bluebook
RICHARD A PARISI, NPI 1104813765, CMS profile ID 140305, IndustryPayments, General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 3 of 3; records 101–136 of 136 matching records. This page contains 36 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e. https://industrypayments.org/provider/npi-1104813765?year=2025&recipient=provider&page=3#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2025 · Physicians and non-physician practitioners · CMS publication 2026-06-30

136 matching records · $3,285.06 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 136 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 101–136 of 136.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
AstraZeneca Pharmaceuticals LP $20.8704/09/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1206682561 CMS
AstraZeneca Pharmaceuticals LP $20.0504/08/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1206943371 CMS
Viatris Specialty LLC $18.8204/07/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1238497277 CMS
Resmed Corp $26.5904/02/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1214126204 CMS
Axsome Therapeutics, Inc. $16.8503/27/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1235638392 CMS
GlaxoSmithKline, LLC. $26.8003/26/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1190919582 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $33.0103/24/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1222726229 CMS
HARMONY BIOSCIENCES LLC $22.7703/20/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1222403424 CMS
Inspire Medical Systems, Inc. $74.3603/19/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1251496801 CMS
Verona Pharma, Inc. $18.4603/19/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1233755445 CMS
AstraZeneca Pharmaceuticals LP $16.1303/18/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1206551357 CMS
JAZZ PHARMACEUTICALS INC. $27.8003/17/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1234325331 CMS
Regeneron Healthcare Solutions, Inc. $18.8503/13/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1213006920 CMS
Lilly USA, LLC $18.1203/12/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1186905814 CMS
PFIZER INC. $14.0303/10/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1231592436 CMS
AstraZeneca Pharmaceuticals LP $22.9603/06/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1206211211 CMS
AstraZeneca Pharmaceuticals LP $14.9203/05/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1207202868 CMS
Inspire Medical Systems, Inc. $39.3303/04/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1251496799 CMS
AstraZeneca Pharmaceuticals LP $21.0302/26/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1206151209 CMS
Viatris Specialty LLC $20.9202/26/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1238496237 CMS
Axsome Therapeutics, Inc. $20.8102/24/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1235360489 CMS
Verona Pharma, Inc. $17.5602/17/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1233755465 CMS
Amgen Inc. $26.4302/12/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1228687416 CMS
JAZZ PHARMACEUTICALS INC. $32.4202/11/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1234319898 CMS
Regeneron Healthcare Solutions, Inc. $20.6102/10/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1213006918 CMS
GlaxoSmithKline, LLC. $23.0002/04/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1191031610 CMS
Inspire Medical Systems, Inc. $33.5302/04/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1251496797 CMS
Viatris Specialty LLC $23.1702/03/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1238489482 CMS
Pulmonx Corporation $23.0601/28/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1199545809 CMS
Axsome Therapeutics, Inc. $11.7901/27/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1235360478 CMS
GlaxoSmithKline, LLC. $23.3401/22/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1190682963 CMS
JAZZ PHARMACEUTICALS INC. $125.7601/22/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1234306022 CMS
Regeneron Healthcare Solutions, Inc. $27.6401/15/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1213006916 CMS
Grifols USA, LLC $21.5601/14/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1249581126 CMS
Verona Pharma, Inc. $24.7401/13/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1233755477 CMS
Amgen Inc. $19.2301/08/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1228687414 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $356.33 18
PY2020 $84.34 5
PY2021 $72.03 4
PY2022 $262.09 5
PY2023 $1,605.81 63
PY2024 $2,382.26 95
PY2025 $3,285.06 136

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $533,349.42 36
PY2024 Principal investigator $92,512.67 22
PY2023 Principal investigator $18,772.46 12
PY2022 Principal investigator $5,865.30 1

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

36 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Avadel CNS Pharmaceuticals, LLC $21,206.06 12/31/2025 Covered Recipient Teaching Hospital
CLEVELAND CLINIC HOSPITAL
A DOUBLE-BLIND, PLACEBO-CONTROLLED, RANDOMIZED WITHDRAWAL, MULTICENTER STUDY OF THE EFFICACY AND SAFETY OF FT218 IN THE TREATMENT OF IDIOPATHIC HYPERSOMNIA (IH) No dispute reported 06/30/2026 1208554175
Principal investigator 1 Avadel CNS Pharmaceuticals, LLC $97,616.47 12/31/2025 Non-covered Recipient Entity
TPMG CLINICAL RESEARCH WILLIAMSBURG
A DOUBLE-BLIND, PLACEBO-CONTROLLED, RANDOMIZED WITHDRAWAL, MULTICENTER STUDY OF THE EFFICACY AND SAFETY OF FT218 IN THE TREATMENT OF IDIOPATHIC HYPERSOMNIA (IH) No dispute reported 06/30/2026 1208554211
Principal investigator 1 Avadel CNS Pharmaceuticals, LLC $78,717.55 12/31/2025 Non-covered Recipient Entity
CLAYTON SLEEP INSTITUTE LLC
A DOUBLE-BLIND, PLACEBO-CONTROLLED, RANDOMIZED WITHDRAWAL, MULTICENTER STUDY OF THE EFFICACY AND SAFETY OF FT218 IN THE TREATMENT OF IDIOPATHIC HYPERSOMNIA (IH) No dispute reported 06/30/2026 1208554213
Principal investigator 1 Avadel CNS Pharmaceuticals, LLC $21,500.00 12/31/2025 Non-covered Recipient Entity
VELOCITY CLINICAL RESEARCH INC
A DOUBLE-BLIND, PLACEBO-CONTROLLED, RANDOMIZED WITHDRAWAL, MULTICENTER STUDY OF THE EFFICACY AND SAFETY OF FT218 IN THE TREATMENT OF IDIOPATHIC HYPERSOMNIA (IH) No dispute reported 06/30/2026 1208554215
Principal investigator 1 Avadel CNS Pharmaceuticals, LLC $13,500.00 12/31/2025 Non-covered Recipient Entity
PHOENIX MEDICAL GROUP PC
A DOUBLE-BLIND, PLACEBO-CONTROLLED, RANDOMIZED WITHDRAWAL, MULTICENTER STUDY OF THE EFFICACY AND SAFETY OF FT218 IN THE TREATMENT OF IDIOPATHIC HYPERSOMNIA (IH) No dispute reported 06/30/2026 1208554217
Principal investigator 1 Avadel CNS Pharmaceuticals, LLC $97,698.62 12/31/2025 Non-covered Recipient Entity
UNIVERSITY OF KANSAS MEDICAL CENTER RESEARCH INSTITUTE INC DBA KUMC RESEARCH INSTITUTE
A DOUBLE-BLIND, PLACEBO-CONTROLLED, RANDOMIZED WITHDRAWAL, MULTICENTER STUDY OF THE EFFICACY AND SAFETY OF FT218 IN THE TREATMENT OF IDIOPATHIC HYPERSOMNIA (IH) No dispute reported 06/30/2026 1208554219
Principal investigator 1 Avadel CNS Pharmaceuticals, LLC $41,505.43 12/31/2025 Non-covered Recipient Entity
STATE OF WEST VIRGINIA DBA WEST VIRGINIA UNIVERSITY
A DOUBLE-BLIND, PLACEBO-CONTROLLED, RANDOMIZED WITHDRAWAL, MULTICENTER STUDY OF THE EFFICACY AND SAFETY OF FT218 IN THE TREATMENT OF IDIOPATHIC HYPERSOMNIA (IH) No dispute reported 06/30/2026 1208554221
Principal investigator 1 Teva Pharmaceuticals USA, Inc. $6,419.93 12/11/2025 Non-covered Recipient Entity
TIDEWATER PHYSICIANS MULTISPECIALTY GROUP PC
A Randomized, Double-Blind, Multicenter, Active-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Fluticasone Propionate/Albuterol Sulfate Fixed-Dose Combination on Severe Asthma Exacerbations in Patients With Asthma No dispute reported 06/30/2026 1244046970
Principal investigator 1 Verona Pharma, Inc. $24,411.24 11/07/2025 Non-covered Recipient Entity
TIDEWATER PHYSICIANS MULTISPEC
Verona No dispute reported 06/30/2026 1232892223
Principal investigator 1 GlaxoSmithKline, LLC. $2,601.90 10/17/2025 Non-covered Recipient Entity
TIDEWATER PHYSICIANS MULTISPECIALTY GROUP PC
A PHASE 3, 52-WEEK, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARA No dispute reported 06/30/2026 1192183951
Principal investigator 1 AstraZeneca Pharmaceuticals LP $433.80 10/08/2025 Non-covered Recipient Entity
TIDEWATER PHYSICIANS MULTISPECIALTY GROUP YORKTOWN FAMILY MEDICINE
A 24-Week Efficacy and Safety Study to Assess Budesonide and Formoterol Fumarate Metered Dose Inhaler in Adult and Adolescent Participants With Inadequately Controlled Asthma No dispute reported 06/30/2026 1185552917
Principal investigator 1 Verona Pharma, Inc. $350.00 09/17/2025 Non-covered Recipient Entity
TIDEWATER PHYSICIANS MULTISPEC
Verona No dispute reported 06/30/2026 1232892128
Principal investigator 1 Verona Pharma, Inc. $500.00 09/17/2025 Non-covered Recipient Entity
TIDEWATER PHYSICIANS MULTISPEC
Verona No dispute reported 06/30/2026 1232892130
Principal investigator 1 Verona Pharma, Inc. $1,000.00 09/17/2025 Non-covered Recipient Entity
TIDEWATER PHYSICIANS MULTISPEC
Verona No dispute reported 06/30/2026 1232892132
Principal investigator 1 GlaxoSmithKline, LLC. $1,421.10 09/03/2025 Non-covered Recipient Entity
TIDEWATER PHYSICIANS MULTISPECIALTY GROUP PC
A PHASE 3, 52-WEEK, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARA No dispute reported 06/30/2026 1192183923
Principal investigator 1 GlaxoSmithKline, LLC. $1,718.00 08/25/2025 Non-covered Recipient Entity
TIDEWATER PHYSICIANS MULTISPECIALTY GROUP PC
A 52-WEEK, RANDOMISED, DOUBLE-BLIND, DOUBLE-DUMMY, PARALLEL GROUP, MUL No dispute reported 06/30/2026 1192181728
Principal investigator 1 GlaxoSmithKline, LLC. $2,901.00 08/25/2025 Non-covered Recipient Entity
TIDEWATER PHYSICIANS MULTISPECIALTY GROUP PC
A 52-WEEK, RANDOMISED, DOUBLE-BLIND, DOUBLE-DUMMY, PARALLEL GROUP, MUL No dispute reported 06/30/2026 1192181737
Principal investigator 1 Verona Pharma, Inc. $350.00 08/08/2025 Non-covered Recipient Entity
TIDEWATER PHYSICIANS MULTISPEC
Verona No dispute reported 06/30/2026 1232892126
Principal investigator 1 AstraZeneca Pharmaceuticals LP $17,500.00 08/07/2025 Non-covered Recipient Entity
TIDEWATER PHYSICIANS MULTISPECIALTY GROUP YORKTOWN FAMILY MEDICINE
Randomized, Double-blind, Placebo-controlled, Parallel Group, Multicenter, Phase 3 Study to Evaluate the Efficacy and Safety of Tezepelumab in Adult Participants with Moderate to Very Severe Chronic Obstructive Pulmonary Disease COPD No dispute reported 06/30/2026 1185552911
Principal investigator 1 GlaxoSmithKline, LLC. $674.10 08/04/2025 Non-covered Recipient Entity
TIDEWATER PHYSICIANS MULTISPECIALTY GROUP PC
A PHASE 3, 52-WEEK, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARA No dispute reported 06/30/2026 1192152238
Principal investigator 1 GlaxoSmithKline, LLC. $2,095.20 07/23/2025 Non-covered Recipient Entity
TIDEWATER PHYSICIANS MULTISPECIALTY GROUP PC
A PHASE 3, 52-WEEK, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARA No dispute reported 06/30/2026 1192183917
Principal investigator 1 GlaxoSmithKline, LLC. $1,119.60 06/20/2025 Non-covered Recipient Entity
TIDEWATER PHYSICIANS MULTISPECIALTY GROUP PC
A PHASE 3, 52-WEEK, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARA No dispute reported 06/30/2026 1192183933
Principal investigator 1 Verona Pharma, Inc. $4,798.21 06/18/2025 Non-covered Recipient Entity
TIDEWATER PHYSICIANS MULTISPEC
Verona No dispute reported 06/30/2026 1232892092
Principal investigator 1 Verona Pharma, Inc. $1,350.00 06/13/2025 Non-covered Recipient Entity
TIDEWATER PHYSICIANS MULTISPEC
Verona No dispute reported 06/30/2026 1232892100
Principal investigator 1 GlaxoSmithKline, LLC. $700.00 06/06/2025 Non-covered Recipient Entity
TIDEWATER PHYSICIANS MULTISPECIALTY GROUP PC
A PHASE 3, 52-WEEK, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARA No dispute reported 06/30/2026 1192181733
Principal investigator 1 AstraZeneca Pharmaceuticals LP $36,370.90 05/23/2025 Non-covered Recipient Entity
TIDEWATER PHYSICIANS MULTISPECIALTY GROUP YORKTOWN FAMILY MEDICINE
A Phase III, Multicentre, Randomised, Double-blind, Chronic-dosing, Parallel-group, Placebo-controlled Extension Study to Evaluate the Long-term Efficacy and Safety of Tozorakimab (MEDI3506) in Participants with Chronic Obstructive Pulmonary Disease (COPD) with a History of Exacerbations No dispute reported 06/30/2026 1185552909
Principal investigator 1 GlaxoSmithKline, LLC. $2,182.50 05/21/2025 Non-covered Recipient Entity
TIDEWATER PHYSICIANS MULTISPECIALTY GROUP PC
A PHASE 3, 52-WEEK, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARA No dispute reported 06/30/2026 1192152234
Principal investigator 1 Verona Pharma, Inc. $15,338.87 05/02/2025 Non-covered Recipient Entity
TIDEWATER PHYSICIANS MULTISPEC
Verona No dispute reported 06/30/2026 1232892090
Principal investigator 1 Verona Pharma, Inc. $10,500.00 04/01/2025 Non-covered Recipient Entity
TIDEWATER PHYSICIANS MULTISPEC
Verona No dispute reported 06/30/2026 1232892102
Principal investigator 1 AstraZeneca Pharmaceuticals LP $2,507.61 03/24/2025 Non-covered Recipient Entity
TIDEWATER PHYSICIANS MULTISPECIALTY GROUP YORKTOWN FAMILY MEDICINE
The CHRONICLE Study is a multi center,non interventional,prospective cohort study of adults with severe asthma who do not achieve control with high-dose ICS therapy with additional controllers and or require systemic corticosteroid or monoclonal antibod No dispute reported 06/30/2026 1185552913
Principal investigator 1 GlaxoSmithKline, LLC. $438.30 02/25/2025 Non-covered Recipient Entity
TIDEWATER PHYSICIANS MULTISPECIALTY GROUP PC
A PHASE 3, 52-WEEK, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARA No dispute reported 06/30/2026 1192181724
Principal investigator 1 Teva Pharmaceuticals USA, Inc. $204.60 02/24/2025 Non-covered Recipient Entity
TIDEWATER PHYSICIANS MULTISPECIALTY GROUP PC
A Randomized, Double-Blind, Multicenter, Active-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Fluticasone Propionate/Albuterol Sulfate Fixed-Dose Combination on Severe Asthma Exacerbations in Patients With Asthma No dispute reported 06/30/2026 1244046996
Principal investigator 1 AstraZeneca Pharmaceuticals LP $17,519.08 02/19/2025 Non-covered Recipient Entity
TIDEWATER PHYSICIANS MULTISPECIALTY GROUP YORKTOWN FAMILY MEDICINE
A Phase III, Multicentre, Randomised, Double-blind, Chronic-dosing, Parallel-group, Placebo-controlled Study to Evaluate the Efficacy and Safety of Two Dose Regimens of MEDI3506 No dispute reported 06/30/2026 1185552915
Principal investigator 1 GlaxoSmithKline, LLC. $1,557.90 01/24/2025 Non-covered Recipient Entity
TIDEWATER PHYSICIANS MULTISPECIALTY GROUP PC
A PHASE 3, 52-WEEK, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARA No dispute reported 06/30/2026 1192183928
Principal investigator 1 Verona Pharma, Inc. $1,500.00 01/17/2025 Non-covered Recipient Entity
TIDEWATER PHYSICIANS MULTISPEC
Verona No dispute reported 06/30/2026 1232892052
Principal investigator 1 Teva Pharmaceuticals USA, Inc. $3,141.45 01/16/2025 Non-covered Recipient Entity
TIDEWATER PHYSICIANS MULTISPECIALTY GROUP PC
A Randomized, Double-Blind, Multicenter, Active-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Fluticasone Propionate/Albuterol Sulfate Fixed-Dose Combination on Severe Asthma Exacerbations in Patients With Asthma No dispute reported 06/30/2026 1244046968